This report is the latest in a series published jointly by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe that has been reporting data on HIV and AIDS in the WHO European Region and in the European Union and European Economic Area (EU/EEA) since 2007.
By 2021, 48 of 55 countries in Europe and Central Asia provided data on at least one stage of the continuum of HIV care (compared to 40 countries in 2018). A total of 47 countries were able to provide data for at least two consecutive stages of the continuum (compared to 45 in 2020) and 40 countries provided data on all four stages.
The purpose of this review was to identify and synthesise the existing evidence on effectiveness of interventions targeting people who inject drugs at two stages of the care cascade: linkage to care and adherence to treatment of HIV, hepatitis B/C and TB.
This report documents the process and outcome of the assessment and translation of the evidence into guidance recommendations on linkage to care and/or adherence to treatment for HCV, HIV and TB for the ECDC technical report, ‘A systematic literature review of interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugs’.
Anthrax continues to be a rare disease in humans in Europe, with only a few cases reported every year. For 2017, two European Union/European Economic Area (EU/EEA) countries reported six confirmed anthrax cases (Romania reported five cases and Bulgaria one). The remaining 28 reporting countries did not notify any confirmed cases.
Anthrax continues to be an uncommon disease in humans in Europe, with only a few cases reported every year. For 2018, three confirmed anthrax cases were reported, one each in Netherlands, Romania and Spain. Twenty-seven EU/EEA countries notified zero confirmed cases.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 31 July-6 August and includes updates on West Nile virus infection, monkeypox, COVID-19, cholera, diphteria, anthrax, Vibrio growth, Marburg virus disease, mass gatherings at the Birmingham 2022 Commonwealth games, MERS-CoV, and Poliovirus.